Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fresh Tracks Therapeutics Inc FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Recent & Breaking News (OTCPK:FRTX)

8 Biggest Mid-Day Losers For Monday

Benzinga.com  September 19, 2016

Mid-Day Market Update: Crude Oil Up 2%; Sarepta Therapeutics Shares Spike Higher

Benzinga.com  September 19, 2016

Mid-Morning Market Update: Markets Open Higher; Tech Data To Buy Technology Solutions From Avnet

Benzinga.com  September 19, 2016

15 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  September 19, 2016

Vical and Astellas Announce Topline Results from a Phase 2 Study of Investigational Cytomegalovirus (CMV) Vaccine (ASP0113) in Kidney Transplant Patients

GlobeNewswire September 19, 2016

Vical to Present at the 18th Annual Rodman & Renshaw Global Investment Conference

GlobeNewswire September 2, 2016

Vical Reports Second Quarter 2016 Financial Results

GlobeNewswire August 9, 2016

Investor Calendar Invites You to the Vical Second Quarter 2016 Earnings Webcast Live on Tuesday, August 9, 2016

Accesswire August 8, 2016

Vical Announces News Release and Conference Call Schedule for Second Quarter 2016 Financial Results

GlobeNewswire August 2, 2016

Vical Announces $7.8 Million Equity Investment by Partner, AnGes MG

GlobeNewswire August 1, 2016

Vical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months

GlobeNewswire June 20, 2016

Vical to Present HSV-2 Phase 1/2 Data at June ASM Microbe/ICAAC 2016 Conference

GlobeNewswire June 13, 2016

Vical Provides VL-2397 Updates at BIO International Convention

GlobeNewswire May 31, 2016

Vical Reports First Quarter 2016 Financial Results

GlobeNewswire May 9, 2016

Investor Calendar Invites You to the Vical First Quarter 2016 Earnings Webcast Live on Monday, May 9, 2016

Accesswire May 6, 2016

Vical Announces News Release and Conference Call Schedule for First Quarter 2016 Financial Results

GlobeNewswire May 2, 2016

FDA Grants Vical Fast Track Designation for VL-2397 for the Treatment of Invasive Aspergillosis

GlobeNewswire March 30, 2016

Vical Reports Fourth Quarter 2015 Financial Results

GlobeNewswire March 14, 2016

Investor Calendar Invites You to the Vical Fourth Quarter and Fiscal Year 2015 Earnings Webcast Live on Monday, March 14, 2016

Accesswire March 11, 2016

Vical to Present at the 28th Annual ROTH Conference

GlobeNewswire March 9, 2016